CAS No. |
129791-92-0 |
|---|---|
英文名称 |
- |
别名 |
Q-103229 | 2,7-(Epoxy[1,11,13]pentadecatrienoimino)-6H-benzofuro[4,5-a]phenoxazine-1,6,15(2H)-trione, 25-(acetyloxy)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)-1-piperazinyl]-, (2S,16Z,18E,20S,21S,22R,23R,24R, |
分子式 |
C51H64N4O13 |
分子量 |
941.09 |
精确分子量 |
940.45 |
SMILES |
CO[C@H]1/C=C/O[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(=C5OC6=CC(N7CCN(CC(C)C)CC7)=CC(=O)C6=NC5=C4C3=C2O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C |
标准SMILES |
CC(C)CN1CCN(CC1)C1=CC(=O)C2=NC3C(OC2=C1)=C1NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@H](C=CO[C@@]2(C)OC4C(=C2O)C=3C(=C(O)C=4C)C1=O)OC |
用途 |
Rifalazil (ABI-1648; KRM-1648) is an antibiotic with potential applications in the treatment of Chlamydia infections, Clostridioides difficile-associated diarrhea (CDAD), and tuberculosis (TB). It exhibits potent antimicrobial activity against Mycobacterium tuberculosis, Gram-positive bacteria (including methicillin-susceptible and -resistant Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, and Streptococcus pneumoniae), Helicobacter pylori, Chlamydia pneumoniae, and Chlamydia trachomatis, with MIC values ranging from 0.0001 to 0.0313 µg/mL. In vivo studies demonstrate that rifalazil, when combined with isoniazid (INH), significantly reduces Mycobacterium tuberculosis burden in both lungs and spleens of infected mice, supporting its potential for short-course tuberculosis therapy. |
InChIKey |
IXSVOCGZBUJEPI-HTQYORAHSA-N |
|
|
评论 |
|---|